Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11886-020-01293-2 http://scihub22266oqcxt.onion/10.1007/s11886-020-01293-2 32350632!7189178!32350632     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Cardiol+Rep 2020 ; 22 (5): 34 Nephropedia Template TP {{tp|p=32350632|t=2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty |pdf=|usr=}}{{32350632}} gab.com Text Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty JO: Curr Cardiol Rep http://www.kidney.de/pget.php?&tw=1&pmid=32350632 #FOAvip PURPOSE OF REVIEW: COronaVirus Disease 2019 (COVID-19) has spread at unprecedented speed and scale into a global pandemic with cardiovascular risk factors and complications emerging as important disease modifiers. We aim to review available clinical and biomedical literature on cardiovascular risks of COVID-19. RECENT FINDINGS: SARS-CoV2, the virus responsible for COVID-19, enters the cell via ACE2 expressed in select organs. Emerging epidemiological evidence suggest cardiovascular risk factors are associated with increased disease severity and mortality in COVID-19 patients. Patients with a more severe form of COVID-19 are also more likely to develop cardiac complications such as myocardial injury and arrhythmia. The true incidence of and mechanism underlying these events remain elusive. Cardiovascular diseases appear intricately linked with COVID-19, with cardiac complications contributing to the elevated morbidity/mortality of COVID-19. Robust epidemiologic and biologic studies are urgently needed to better understand the mechanism underlying these associations to develop better therapies. Twit Text FOAVip Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty ????Curr Cardiol Rep http://www.kidney.de/pget.php?&tw=1&pmid=32350632 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32350632 #FOAvip English Wikipedia <ref>{{Cite pmid|32350632}}</ref> Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty #MMPMID32350632 Cheng P; Zhu H; Witteles RM; Wu JC; Quertermous T; Wu SM; Rhee JW Curr Cardiol Rep 2020[Apr]; 22 (5): 34 PMID32350632show ga PURPOSE OF REVIEW: COronaVirus Disease 2019 (COVID-19) has spread at unprecedented speed and scale into a global pandemic with cardiovascular risk factors and complications emerging as important disease modifiers. We aim to review available clinical and biomedical literature on cardiovascular risks of COVID-19. RECENT FINDINGS: SARS-CoV2, the virus responsible for COVID-19, enters the cell via ACE2 expressed in select organs. Emerging epidemiological evidence suggest cardiovascular risk factors are associated with increased disease severity and mortality in COVID-19 patients. Patients with a more severe form of COVID-19 are also more likely to develop cardiac complications such as myocardial injury and arrhythmia. The true incidence of and mechanism underlying these events remain elusive. Cardiovascular diseases appear intricately linked with COVID-19, with cardiac complications contributing to the elevated morbidity/mortality of COVID-19. Robust epidemiologic and biologic studies are urgently needed to better understand the mechanism underlying these associations to develop better therapies. |Angiotensin-Converting Enzyme 2[MESH] |Betacoronavirus/metabolism/pathogenicity/ultrastructure[MESH] |COVID-19[MESH] |Cardiovascular Diseases/epidemiology/*mortality/*physiopathology/virology[MESH] |Comorbidity[MESH] |Coronavirus Infections/epidemiology/*mortality/*physiopathology/virology[MESH] |Coronavirus/metabolism/pathogenicity/ultrastructure[MESH] |Humans[MESH] |Pandemics[MESH] |Peptidyl-Dipeptidase A/metabolism[MESH] |Pneumonia, Viral/epidemiology/*mortality/*physiopathology/virology[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms a(epmc).pdf DeepDyve Pubget Overpricing